Fentanyl and Other Synthetics Complicating the Opioid Crisis
Training Description: This lecture will focus on fentanyl and other dangerous synthetics that are entering the drug supply and primarily responsible for the morbidity and mortality trends we are seeing today. The drugs fentanyl, Nitazenes like Isotonitazene (or "Iso"), Xylazine, and Kratom will be the focus of this lecture. Medication Assisted Therapies will be discussed as the gold standard in reducing morbidity and mortality for those active in opioid use disorder. Harm reduction and other supportive endeavors at reducing the impact of these dangerous drugs will be highlighted. Learning Objectives: Objective 1: Discuss why Fentanyl is the so called “Third Wave” of the Opioid Crisis and why is it a problem drug and has exponentially increased overdose deaths in recent years. Objective 2: Identify recent trends and types of synthetics entering the street drug supply and have familiarity with them and approaches to treatment to minimize overdose deaths. Objective 3: Analyze Kratom as an opioid-type drug and identify factors leading to increased availability and use throughout the United States. Objective 4: Describe why Medication Assisted Therapy for opioid use disorder is still best practice for preventing exposure to synthetics and other recent trends in problem drugs. Presenter: Jason Baker Fields MD Baycare Behavioral Health Dr. Fields, is board certified with the American Board of Preventative Medicine in Addiction Medicine. He has been working in addiction treatment for the past 14 years and currently is employed with BayCare Behavioral Health where he does outpatient and inpatient practice. Dr Fields was brought on board by BayCare in 2019 to bring best practice medication assisted treatment to their behavioral health services. Dr. Fields practices largely outpatient in New Port Richey, Florida and is a consultant for inpatients and has hospital privileges at North Bay Hospital. He is a DCF Peer Mentor and helps educated Floridian practitioners looking to bring best practice MAT to their clinics. He is a past president with the Florida Society of Addiction Medicine and current serves as their treasurer. He enjoys presentations on topics in addiction medicine at the local, state and national levels. Dr Fields is also on the board of directors for the Professional Resource Network.
This lecture will focus on fentanyl and other dangerous synthetics that are entering the drug supply and primarily responsible for the morbidity and mortality trends we are seeing today. The drugs fentanyl, Nitazenes like Isotonitazene (or "Iso"), Xylazine, and Kratom will be the focus of this lecture. Medication Assisted Therapies will be discussed as the gold standard in reducing morbidity and mortality for those active in opioid use disorder. Harm reduction and other supportive endeavors at reducing the impact of these dangerous drugs will be highlighted.
Objective 1: Discuss why Fentanyl is the so called “Third Wave” of the Opioid Crisis and why is it a problem drug and has exponentially increased overdose deaths in recent years.
Objective 2: Identify recent trends and types of synthetics entering the street drug supply and have familiarity with them and approaches to treatment to minimize overdose deaths.
Objective 3: Analyze Kratom as an opioid-type drug and identify factors leading to increased availability and use throughout the United States.
Objective 4: Describe why Medication Assisted Therapy for opioid use disorder is still best practice for preventing exposure to synthetics and other recent trends in problem drugs.
Jason Baker Fields MD
Baycare Behavioral Health
Dr. Fields, is board certified with the American Board of Preventative Medicine in Addiction Medicine. He has been working in addiction treatment for the past 14 years and currently is employed with BayCare Behavioral Health where he does outpatient and inpatient practice. Dr Fields was brought on board by BayCare in 2019 to bring best practice medication assisted treatment to their behavioral health services. Dr. Fields practices largely outpatient in New Port Richey, Florida and is a consultant for inpatients and has hospital privileges at North Bay Hospital. He is a DCF Peer Mentor and helps educated Floridian practitioners looking to bring best practice MAT to their clinics. He is a past president with the Florida Society of Addiction Medicine and current serves as their treasurer. He enjoys presentations on topics in addiction medicine at the local, state and national levels. Dr Fields is also on the board of directors for the Professional Resource Network.
Contact: Valentino Norton Phone No. 727.318.7070 Email: Administrator@FSAM.INFO
Contact: Valentino Norton
Phone No. 727.318.7070
Email: Administrator@FSAM.INFO
